ea0013oc23 | Novartis Basic Endocrinology Award | SFEBES2007
Kozak Agnieszka
, Pechenick Jowers Tali
, Hadoke Patrick
, Vale Wylie
, Jamieson Pauline
Stimulation of the corticotropin-releasing factor type 2 receptor (CRFR2) by its putative ligands the urocortins may influence cardiovascular function by regulating vascular tone and angiogenesis.We examined whether chronic exposure to the CRFR2-selective ligand Urocortin 3 altered the ability of the receptor to modulate vascular functions by assessing arterial contractility and angiogenesis in response to Urocortin 3 both in control mice and in transgen...